Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
6.99
-0.50 (-6.68%)
At close: Sep 25, 2026, 4:00 PM EDT
7.02
+0.03 (0.43%)
After-hours: Sep 25, 2026, 7:30 PM EDT
Artiva Biotherapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
115
Market Cap
341.74M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 251.00K | -33.24M | -99.25% |
| Dec 31, 2023 | 33.49M | 28.56M | 579.21% |
| Dec 31, 2022 | 4.93M | 2.93M | 146.30% |
| Dec 31, 2021 | 2.00M | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Enanta Pharmaceuticals | 65.26M |
| Fennec Pharmaceuticals | 59.22M |
| C4 Therapeutics | 35.04M |
| Orchestra BioMed Holdings | 31.98M |
| Surrozen | 11.51M |
| Ocugen | 4.58M |
ARTV News
- 2 days ago - Artiva Biotherapeutics Transcript: Stifel 2026 Virtual Immunology and Inflammation Forum - Transcripts
- 3 days ago - Artiva Biotherapeutics Announces Oral Presentation of AlloNK® Clinical Data at the 17th International Symposium on Sjögren's Disease - GlobeNewsWire
- 9 days ago - Artiva Biotherapeutics to Participate in the Stifel 2026 Virtual Immunology and Inflammation Forum - GlobeNewsWire
- 12 days ago - Artiva Biotherapeutics Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 17 days ago - Artiva Biotherapeutics Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 18 days ago - Artiva Biotherapeutics provides update on AlloNK data disclosures - TheFly
- 18 days ago - Artiva Biotherapeutics Provides Update on Planned AlloNK® Data Disclosures and Development Milestones for the Remainder of 2026 - GlobeNewsWire
- 24 days ago - Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in September - GlobeNewsWire